D. Boral Capital Maintains Buy on VolitionRX, Maintains $5 Price Target
Volitionrx Limited +0.74%
Volitionrx Limited VNRX | 0.57 | +0.74% |
D. Boral Capital analyst Jason Kolbert maintains VolitionRX (AMEX:
VNRX) with a Buy and maintains $5 price target.